Literature DB >> 18809344

Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis.

T Vinardell1, V Dejica, A R Poole, J S Mort, H Richard, S Laverty.   

Abstract

OBJECTIVE: The mechanisms leading to degeneration of articular cartilage in osteoarthritis (OA) are complex and not yet fully understood. Cathepsin K (CK) is a cysteine protease which can also cleave the triple helix of type II collagen. This exposes a neoepitope that can now be identified by specific antibodies. The aim of this study was to obtain evidence suggesting a role for CK in naturally occurring equine OA in both lesional and peri-lesional regions.
METHODS: Articular cartilages (n=12 horses; 5 healthy, 7 OA) were harvested from animals postmortem. A gross macroscopic examination, histologic (Safranin O-Fast Green and Picrosirius red staining) and immunohistochemical evaluation were performed. Samples were divided into normal appearing cartilage, peri-lesional and lesional cartilage. Cartilage degradation in the samples was graded histologically and immunohistochemically. CK and possible CK cleavage were detected immunohistochemically with specific anti-protein and anti-neoepitope antibodies, respectively. A comparison of CK neoepitope (C2K) production with the collagenase-generated neoepitope produced by matrix metalloproteinases (MMP)-1, 8 and 13 (C2C) was also assessed immunohistochemically.
RESULTS: CK and CK cleavage were significantly more abundant in OA cartilage (both peri-lesional and lesional) when compared to remote cartilage within the sample joint or cartilage from healthy joints. The immunohistochemical pattern observed for CK degradation (C2K) was similar to that of collagenase degradation (C2C). Macroscopic cartilage changes and histologic findings were significantly correlated with immunohistochemistry results.
CONCLUSION: The data generated suggests that CK may be involved in cartilage collagen degradation in naturally occurring osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809344     DOI: 10.1016/j.joca.2008.07.017

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  9 in total

1.  Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study.

Authors:  Pengfei Hu; Weiping Chen; Jiapeng Bao; Lifeng Jiang; Lidong Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.

Authors:  C B Little; A Barai; D Burkhardt; S M Smith; A J Fosang; Z Werb; M Shah; E W Thompson
Journal:  Arthritis Rheum       Date:  2009-12

Review 3.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

4.  Carrageenan-induced transient inflammation in a rabbit knee model: molecular changes consistent with an early osteoarthritis phenotype.

Authors:  Yamini Achari; Carol R Reno; Cyril B Frank; David A Hart
Journal:  Inflamm Res       Date:  2012-05-13       Impact factor: 4.575

5.  Overexpression of cystatin C in synovium does not reduce synovitis or cartilage degradation in established osteoarthritis.

Authors:  Sirkka Kyostio-Moore; Susan Piraino; Patricia Berthelette; Nance Moran; Joseph Serriello; Alison Bendele; Cathleen Sookdeo; Bindu Nambiar; Patty Ewing; Donna Armentano; Gloria L Matthews
Journal:  Arthritis Res Ther       Date:  2015-01-16       Impact factor: 5.156

6.  Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage.

Authors:  Valeria M Dejica; John S Mort; Sheila Laverty; John Antoniou; David J Zukor; Michael Tanzer; A Robin Poole
Journal:  Arthritis Res Ther       Date:  2012-05-14       Impact factor: 5.156

7.  Cathepsin K Localizes to Equine Bone In Vivo and Inhibits Bone Marrow Stem and Progenitor Cells Differentiation In Vitro.

Authors:  Hayam Hussein; Prosper Boyaka; Jennifer Dulin; Duncan Russell; Lauren Smanik; Mohamed Azab; Alicia L Bertone
Journal:  J Stem Cells Regen Med       Date:  2017-12-18

8.  Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis pain.

Authors:  Lilian N Nwosu; Peter R W Gowler; James J Burston; Biljana Rizoska; Karin Tunblad; Erik Lindström; Urszula Grabowska; Li Li; Dan F McWilliams; David A Walsh; Victoria Chapman
Journal:  Pain Rep       Date:  2018-10-05

Review 9.  The Bone Cartilage Interface and Osteoarthritis.

Authors:  Alan Boyde
Journal:  Calcif Tissue Int       Date:  2021-06-04       Impact factor: 4.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.